UB Paderborn / Katalog / Suche / in CDI

1 – 21 von 21

Sortiert nach

BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours

BMJ open, 2022-05, Vol.12 (5), p.e060342-e060342

2022

Link zum Volltext

Verfügbarkeit prüfen

Early Detection of Circulating Tumor DNA Postoperatively Enables Discovery of Resectable Metastatic Disease in a Patient with Colon Cancer

Case reports in oncology, 2021-12, Vol.14 (3), p.1748-1753

2021

Link zum Volltext

Verfügbarkeit prüfen

Circulating tumor DNA (ctDNA) serial analysis during progression on PD-1 blockade and later CTLA-4 rescue in patients with mismatch repair deficient metastatic colorectal cancer

Journal for immunotherapy of cancer, 2022-01, Vol.10 (1), p.e003312

2022

Link zum Volltext

Verfügbarkeit prüfen

Personalized, tumor‐informed, circulating tumor DNA assay for detecting minimal residual disease in non‐small cell lung cancer patients receiving curative treatments

Thoracic cancer, 2024-05, Vol.15 (13), p.1095-1102

2024

Link zum Volltext

Verfügbarkeit prüfen

ctDNA Clearance and Radiographic Resolution of Disease in Response to Dual Checkpoint Inhibition in Metastatic Microsatellite Stable Colorectal Cancer with a High Tumor Mutation Burden

Case reports in oncology, 2021-06, Vol.14 (2), p.849-853

2021

Link zum Volltext

Verfügbarkeit prüfen

The Utility of Circulating Tumor DNA (ctDNA) Monitoring in Cancer Patients Who Are Pregnant or Planning to Become Pregnant

Case reports in obstetrics and gynecology, 2022, Vol.2022, p.9412201-5

2022

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal circulating tumor DNA monitoring for detection of molecular residual disease in patients with surgically resected stage II/III melanoma

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.9582-9582

2023

Link zum Volltext

Verfügbarkeit prüfen

Early real-world experience monitoring circulating tumor DNA in resected early-stage non–small cell lung cancer

The Journal of thoracic and cardiovascular surgery, 2024-01

2024

Link zum Volltext

Verfügbarkeit prüfen

Recent advancements in understanding endogenous heart regeneration—insights from adult zebrafish and neonatal mice

Seminars in cell & developmental biology, 2016-10, Vol.58, p.34-40

2016

Link zum Volltext

Verfügbarkeit prüfen

Prospective study of the co-relation of ctDNA with pathologic complete remission (pCR) and other efficacy outcomes in rectal cancer patients undergoing neoadjuvant chemotherapy and radiation

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.TPS235-TPS235

2022

Link zum Volltext

Verfügbarkeit prüfen

Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non-Small Cell Lung Cancer

Clinical cancer research, 2023-11, Vol.29 (22), p.4596

2023

Link zum Volltext

Verfügbarkeit prüfen

Rac1 modulates mammalian lung branching morphogenesis in part through canonical Wnt signaling

American journal of physiology. Lung cellular and molecular physiology, 2016-12, Vol.311 (6), p.L1036-L1049

2016

Link zum Volltext

Verfügbarkeit prüfen

Mesenchymal and Epithelial Specific Deletion of Rac1 Prevents Lung Morphogenesis

The FASEB journal, 2016-04, Vol.30 (S1)

2016

Link zum Volltext

Verfügbarkeit prüfen

Circulating tumor DNA (ctDNA) monitoring to inform maintenance outcomes in patients (pts) with advanced NSCLC treated with induction atezolizumab+carboplatin+nab-paclitaxel (A+CnP)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.9075-9075

2023

Link zum Volltext

Verfügbarkeit prüfen

Tumor-informed assessment of circulating tumor DNA and its incorporation into practice for patients with hepatobiliary cancers

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.4103-4103

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract 19018: Histone 3 Lysine 4 Tri-Methylation is Necessary for Epicardial Epithelial-to-mesenchymal Transformation

Circulation (New York, N.Y.), 2015-11, Vol.132 (Suppl_3 Suppl 3), p.A19018-A19018

2015

Link zum Volltext

Verfügbarkeit prüfen

Histone 3 Lysine 4 Tri-Methylation in the Regulation of Epicardial Epithelial-to-Mesenchymal Transformation

Krainock, Michael R

2015

Link zum Volltext
ProQuest

Early Detection of Circulating Tumor DNA Postoperatively Enables Discovery of Resectable Metastatic Disease in a Patient with Colon Cancer

Case reports in oncology, 2021, Vol.14 (3), p.1748-1753

2021

Link zum Volltext

Verfügbarkeit prüfen

ctDNA Clearance and Radiographic Resolution of Disease in Response to Dual Checkpoint Inhibition in Metastatic Microsatellite Stable Colorectal Cancer with a High Tumor Mutation Burden

Case reports in oncology, 2021, Vol.14 (2), p.849-853

2021

Link zum Volltext

Verfügbarkeit prüfen

The Utility of Circulating Tumor DNA (ctDNA) Monitoring in Cancer Patients Who Are Pregnant or Planning to Become Pregnant

Case reports in obstetrics and gynecology, 2022, Vol.2022, p.9412201-9412201

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(19)

Publikationsform

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours

Early Detection of Circulating Tumor DNA Postoperatively Enables Discovery of Resectable Metastatic Disease in a Patient with Colon Cancer

Circulating tumor DNA (ctDNA) serial analysis during progression on PD-1 blockade and later CTLA-4 rescue in patients with mismatch repair deficient metastatic colorectal cancer

Personalized, tumor‐informed, circulating tumor DNA assay for detecting minimal residual disease in non‐small cell lung cancer patients receiving curative treatments

ctDNA Clearance and Radiographic Resolution of Disease in Response to Dual Checkpoint Inhibition in Metastatic Microsatellite Stable Colorectal Cancer with a High Tumor Mutation Burden

The Utility of Circulating Tumor DNA (ctDNA) Monitoring in Cancer Patients Who Are Pregnant or Planning to Become Pregnant

Longitudinal circulating tumor DNA monitoring for detection of molecular residual disease in patients with surgically resected stage II/III melanoma

Early real-world experience monitoring circulating tumor DNA in resected early-stage non–small cell lung cancer

Recent advancements in understanding endogenous heart regeneration—insights from adult zebrafish and neonatal mice

Prospective study of the co-relation of ctDNA with pathologic complete remission (pCR) and other efficacy outcomes in rectal cancer patients undergoing neoadjuvant chemotherapy and radiation

Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non-Small Cell Lung Cancer

Rac1 modulates mammalian lung branching morphogenesis in part through canonical Wnt signaling

Mesenchymal and Epithelial Specific Deletion of Rac1 Prevents Lung Morphogenesis

Circulating tumor DNA (ctDNA) monitoring to inform maintenance outcomes in patients (pts) with advanced NSCLC treated with induction atezolizumab+carboplatin+nab-paclitaxel (A+CnP)

Tumor-informed assessment of circulating tumor DNA and its incorporation into practice for patients with hepatobiliary cancers

Abstract 19018: Histone 3 Lysine 4 Tri-Methylation is Necessary for Epicardial Epithelial-to-mesenchymal Transformation

ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy

Histone 3 Lysine 4 Tri-Methylation in the Regulation of Epicardial Epithelial-to-Mesenchymal Transformation

Early Detection of Circulating Tumor DNA Postoperatively Enables Discovery of Resectable Metastatic Disease in a Patient with Colon Cancer

ctDNA Clearance and Radiographic Resolution of Disease in Response to Dual Checkpoint Inhibition in Metastatic Microsatellite Stable Colorectal Cancer with a High Tumor Mutation Burden

The Utility of Circulating Tumor DNA (ctDNA) Monitoring in Cancer Patients Who Are Pregnant or Planning to Become Pregnant

Suchergebnisse filtern